{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:18:32Z","timestamp":1787732312185,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.maturitas.2020.12.012","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T07:37:29Z","timestamp":1610091449000},"page":"73-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman\u2019s life: Implications for the efficacy and safety of novel antimigraine medications"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0089-8773","authenticated-orcid":false,"given":"Simone","family":"de Vries Lentsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-3632","authenticated-orcid":false,"given":"Elo\u00edsa","family":"Rubio-Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.maturitas.2020.12.012_bib0005","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s40265-018-0923-5","article-title":"CGRP and migraine: the role of blocking calcitonin gene-related peptide ligand and receptor in the management of migraine","volume":"78","author":"Maasumi","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"Trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cat","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans","author":"de Vries","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.maturitas.2020.12.012_bib0025","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen","year":"2002","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.maturitas.2020.12.012_bib0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12883-020-01633-3","article-title":"Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine - an updated systematic review and meta-analysis","volume":"20","author":"Deng","year":"2020","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.maturitas.2020.12.012_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/0333102417739584","article-title":"Gender aspects of CGRP in migraine","volume":"39","author":"Labastida-Ramirez","year":"2017","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.maturitas.2020.12.012_bib0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.tips.2016.06.002","article-title":"Wiping out CGRP: potential cardiovascular risks","volume":"37","author":"MaassenVanDenBrink","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.maturitas.2020.12.012_bib0055","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/head.12150","article-title":"Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study","volume":"53","author":"Buse","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0060","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","article-title":"Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen","volume":"67","author":"MacGregor","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.maturitas.2020.12.012_bib0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2014.05.018","article-title":"Migraine and perimenopause","volume":"78","author":"Ibrahimi","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.0000000000001142","article-title":"Reduced trigeminovascular cyclicity in patients with menstrually related migraine","volume":"84","author":"Ibrahimi","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.maturitas.2020.12.012_bib0075","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1212\/WNL.0000000000005855","article-title":"Female sex hormones in men with migraine","volume":"91","author":"van Oosterhout","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.maturitas.2020.12.012_bib0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1043-2760(02)00563-5","article-title":"Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity","volume":"13","author":"Yallampalli","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.1469-0705.1997.09020094.x","article-title":"Transvaginal uterine and umbilical artery doppler examination of 12-16 weeks and the subsequent development of pre-eclampsia and intrauterine growth retardartion","volume":"9","author":"Harrington","year":"1997","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.maturitas.2020.12.012_bib0090","doi-asserted-by":"crossref","first-page":"H230","DOI":"10.1152\/ajpheart.00140.2003","article-title":"Involvement of calcitonin gene-related peptide in control of human fetoplacental vascular tone","volume":"286","author":"Dong","year":"2004","journal-title":"Am. J. Physiol. Heart Circulatory Physiol."},{"issue":"5\u20136","key":"10.1016\/j.maturitas.2020.12.012_bib0095","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000181833","article-title":"Evaluation of a peptide family encoded by the calcitonin gene in selected healthy pregnant women. A longitudinal study","volume":"34","author":"Saggese","year":"1990","journal-title":"Hormone Res."},{"issue":"6","key":"10.1016\/j.maturitas.2020.12.012_bib0100","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.ajog.2006.04.006","article-title":"Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies","volume":"195","author":"Dong","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.maturitas.2020.12.012_bib0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042192-200007010-00005","article-title":"Concentrations of calcitonin gene-related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women","volume":"7","author":"Wyon","year":"2000","journal-title":"Menopause (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.maturitas.2020.12.012_bib0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/13697130802378493","article-title":"Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks","volume":"11","author":"Gupta","year":"2008","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.maturitas.2020.12.012_bib0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0378-5122(98)00047-4","article-title":"Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide","volume":"30","author":"Wyon","year":"1998","journal-title":"Maturitas"},{"issue":"5997","key":"10.1016\/j.maturitas.2020.12.012_bib0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/313054a0","article-title":"Calcitonin gene-related peptide is a potent vasodilator","volume":"313","author":"Brain","year":"1985","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.maturitas.2020.12.012_bib0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12020-018-1777-z","article-title":"Is calcitonin gene-related peptide a modulator of menopausal vasomotor symptoms?","volume":"63","author":"Oliveira","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3389\/fphar.2018.01452","article-title":"CGRP is critical for hot flushes in ovariectomized mice","volume":"9","author":"Wilhelms","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3 Pt 1","key":"10.1016\/j.maturitas.2020.12.012_bib0135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/ob.1996.v175.a74287","article-title":"Changes of plasma calcitonin gene-related peptide levels in postmenopausal women","volume":"175","author":"Valentini","year":"1996","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.maturitas.2020.12.012_bib0140","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1530\/eje.0.1370664","article-title":"Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women","volume":"137","author":"Spinetti","year":"1997","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0378-5122(93)90121-W","article-title":"Characteristics of headache at menopause: a clinico-epidemiologic study","volume":"17","author":"Neria","year":"1993","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/13697130400012163","article-title":"The menopausal transition: a 9-year prospective populationbased study. The Melbourne Women\u2019s Midlife Health Project","volume":"7","author":"Guthrie","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0155","first-page":"645","article-title":"Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study","volume":"85","author":"Laughlin","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.maturitas.2020.12.012_bib0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/WCO.0000000000000548","article-title":"Calcitonin-gene-related peptide pathway mAbs and migraine prevention","volume":"31","author":"Paemeleire","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.maturitas.2020.12.012_bib0165","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/14740338.2020.1811229","article-title":"CGRP inhibitors for migraine prophylaxis: a safety review","volume":"19","author":"Rivera-Mancilla","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0170","series-title":"Calcitonin Gene-Related Peptide (CGRP) Mechanisms. Handb Expl Pharmacol.","first-page":"131","article-title":"Understanding CGRP and cardiovascular risk","author":"Rubio-Beltran","year":"2019"},{"issue":"2","key":"10.1016\/j.maturitas.2020.12.012_bib0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1095\/biolreprod67.2.624","article-title":"Infusion of pregnant rats with calcitonin gene-related peptide (CGRP)(8-37), a CGRP receptor antagonist, increases blood pressure and fetal mortality and decreases fetal growth","volume":"67","author":"Gangula","year":"2002","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.maturitas.2020.12.012_bib0180","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/oxfordjournals.humrep.a019274","article-title":"Calcitonin gene-related peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by N(G)-nitro-L-arginine methyl ester","volume":"11","author":"Yallampalli","year":"1996","journal-title":"Hum. Reprod. (Oxford, England)"},{"key":"10.1016\/j.maturitas.2020.12.012_bib0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.yrtph.2019.05.013","article-title":"Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine","volume":"106","author":"Bussiere","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.maturitas.2020.12.012_bib0190","first-page":"1526","article-title":"An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta","volume":"26","author":"Story","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.maturitas.2020.12.012_bib0195","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/gme.0b013e31803c56b6","article-title":"Expression of calcitonin gene-related peptide, adrenomedullin, and receptor modifying proteins in human adipose tissue and alteration in their expression with menopause status","volume":"14","author":"Gupta","year":"2007","journal-title":"Menopause (New York, N.Y.)"},{"issue":"12","key":"10.1016\/j.maturitas.2020.12.012_bib0200","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.0000000000004391","article-title":"Erenumab (AMG 334) in episodic migraine: interim analysis of an ongoing open-label study","volume":"89","author":"Ashina","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.maturitas.2020.12.012_bib0205","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1177\/0333102414527646","article-title":"Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP","volume":"34","author":"Bigal","year":"2014","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.maturitas.2020.12.012_bib0210","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.maturitas.2020.12.012_bib0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0143-4179(97)90046-9","article-title":"The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells","volume":"31","author":"Li","year":"1997","journal-title":"Neuropeptides"},{"issue":"2","key":"10.1016\/j.maturitas.2020.12.012_bib0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1468-2982.2004.00830.x","article-title":"BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers","volume":"25","author":"Petersen","year":"2005","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.maturitas.2020.12.012_bib0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/head.13316","article-title":"Double-blind, placebo-controlled study to evaluate the effect of erenumab on exercise time during a treadmill test in patients with stable angina","volume":"58","author":"Depre","year":"2018","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.maturitas.2020.12.012_bib0230","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/head.13402","article-title":"Is CGRP receptor blockade cardiovascularly safe? Appropriate studies are needed","volume":"58","author":"MaassenVanDenBrink","year":"2018","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.maturitas.2020.12.012_bib0235","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ahj.2007.10.019","article-title":"Angina with \u201cnormal\u201d coronary arteries: sex differences in outcomes","volume":"155","author":"Humphries","year":"2008","journal-title":"Am. Heart J."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220304667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512220304667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:17:47Z","timestamp":1759915067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512220304667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":47,"alternative-id":["S0378512220304667"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.12.012","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing levels of sex hormones and calcitonin gene-related peptide (CGRP) during a woman\u2019s life: Implications for the efficacy and safety of novel antimigraine medications","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2020.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}